
|Articles|April 2, 2020
ERT Enables Trial Continuity Through At-Home Respiratory Solutions
Advertisement
ERT announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits. ERT’s At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patients are limited due to COVID-19 mandates.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
4
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
5




